FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087932012> ?p ?o ?g. }

• W3087932012 endingPage "E1030" @default.
• W3087932012 startingPage "E1019" @default.
• W3087932012 abstract "Glucagon-like peptide-1 (GLP-1) is a novel antidiabetic agent used in clinical practice. Recently, it was reported to exert a renoprotective effect in the human kidney-2 cells and kidneys of diabetic rats, which was induced by one type of GLP-1 analog, liraglutide, in the presence of high glucose. However, most of the previous findings mainly focused on its indirect effect in inhibiting the advanced glycation end products. Here, besides glycemic control, we also demonstrated a stimulatory role of liraglutide in promoting autophagy and relieving oxidative stress in Zucker diabetic fatty rats. The renoprotective effect of liraglutide has been demonstrated by significantly decreasing urinary albumin ( P < 0.01) and ameliorating renal pathological changes ( P < 0.001) in vivo. Besides that, proliferation of human epithelial kidney cell line HKC-8 and human embryonic kidney-293 cells has increased after treating with exendin-4, a GLP-1 receptor (GLP-1R) agonist. Moreover, GLP-1 could positively improve the progression of autophagy in vivo and in vitro through regulating the autophagy-related protein light chain 3 and p62 via AMP-activated protein kinase (AMPK)-mammalian target of rapamycin (mTOR) signaling pathway. Simultaneously, it could reverse NF-erythroid 2-related factor 2 (NRF2) translocation into the nuclei and suppress oxidative stress. In terms of mechanism, the renoprotective effect of GLP-1 would be exerted via the GLP-1R-AMPK-mTOR-autophagy-reactive oxygen species signaling axis. The present study not only illustrates the renoprotective effect of GLP-1 in diabetic kidney disease (DKD) rats, but also for the first time elucidates the underlying mechanism that is independent of controlling glucose, which implies that GLP-1 might be a novel therapeutic strategy for the prevention and treatment of DKD." @default.
• W3087932012 created "2020-10-01" @default.
• W3087932012 creator A5009487022 @default.
• W3087932012 creator A5016771369 @default.
• W3087932012 creator A5035639631 @default.
• W3087932012 creator A5038055068 @default.
• W3087932012 creator A5047428032 @default.
• W3087932012 creator A5056012897 @default.
• W3087932012 creator A5061894086 @default.
• W3087932012 creator A5066269229 @default.
• W3087932012 date "2020-12-01" @default.
• W3087932012 modified "2023-10-11" @default.
• W3087932012 title "Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway" @default.
• W3087932012 cites W1985124617 @default.
• W3087932012 cites W1985922411 @default.
• W3087932012 cites W1990927292 @default.
• W3087932012 cites W1991265255 @default.
• W3087932012 cites W2009530082 @default.
• W3087932012 cites W2013381376 @default.
• W3087932012 cites W2049082976 @default.
• W3087932012 cites W2050349024 @default.
• W3087932012 cites W2084948079 @default.
• W3087932012 cites W2088977563 @default.
• W3087932012 cites W2089333697 @default.
• W3087932012 cites W2119399459 @default.
• W3087932012 cites W2124831863 @default.
• W3087932012 cites W2127883421 @default.
• W3087932012 cites W2128562466 @default.
• W3087932012 cites W2136066105 @default.
• W3087932012 cites W2145824107 @default.
• W3087932012 cites W2147571221 @default.
• W3087932012 cites W2156144699 @default.
• W3087932012 cites W2179291431 @default.
• W3087932012 cites W2215856261 @default.
• W3087932012 cites W2336537413 @default.
• W3087932012 cites W2340643800 @default.
• W3087932012 cites W2896444158 @default.
• W3087932012 cites W2907161135 @default.
• W3087932012 doi "https://doi.org/10.1152/ajpendo.00195.2019" @default.
• W3087932012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32985256" @default.
• W3087932012 hasPublicationYear "2020" @default.
• W3087932012 type Work @default.
• W3087932012 sameAs 3087932012 @default.
• W3087932012 citedByCount "21" @default.
• W3087932012 countsByYear W30879320122021 @default.
• W3087932012 countsByYear W30879320122022 @default.
• W3087932012 countsByYear W30879320122023 @default.
• W3087932012 crossrefType "journal-article" @default.
• W3087932012 hasAuthorship W3087932012A5009487022 @default.
• W3087932012 hasAuthorship W3087932012A5016771369 @default.
• W3087932012 hasAuthorship W3087932012A5035639631 @default.
• W3087932012 hasAuthorship W3087932012A5038055068 @default.
• W3087932012 hasAuthorship W3087932012A5047428032 @default.
• W3087932012 hasAuthorship W3087932012A5056012897 @default.
• W3087932012 hasAuthorship W3087932012A5061894086 @default.
• W3087932012 hasAuthorship W3087932012A5066269229 @default.
• W3087932012 hasConcept C126322002 @default.
• W3087932012 hasConcept C134018914 @default.
• W3087932012 hasConcept C184235292 @default.
• W3087932012 hasConcept C185592680 @default.
• W3087932012 hasConcept C190283241 @default.
• W3087932012 hasConcept C203522944 @default.
• W3087932012 hasConcept C2776151105 @default.
• W3087932012 hasConcept C2777180221 @default.
• W3087932012 hasConcept C2780091579 @default.
• W3087932012 hasConcept C2780124434 @default.
• W3087932012 hasConcept C2781308992 @default.
• W3087932012 hasConcept C55493867 @default.
• W3087932012 hasConcept C555293320 @default.
• W3087932012 hasConcept C62478195 @default.
• W3087932012 hasConcept C71924100 @default.
• W3087932012 hasConcept C86554907 @default.
• W3087932012 hasConcept C97029542 @default.
• W3087932012 hasConcept C98274493 @default.
• W3087932012 hasConceptScore W3087932012C126322002 @default.
• W3087932012 hasConceptScore W3087932012C134018914 @default.
• W3087932012 hasConceptScore W3087932012C184235292 @default.
• W3087932012 hasConceptScore W3087932012C185592680 @default.
• W3087932012 hasConceptScore W3087932012C190283241 @default.
• W3087932012 hasConceptScore W3087932012C203522944 @default.
• W3087932012 hasConceptScore W3087932012C2776151105 @default.
• W3087932012 hasConceptScore W3087932012C2777180221 @default.
• W3087932012 hasConceptScore W3087932012C2780091579 @default.
• W3087932012 hasConceptScore W3087932012C2780124434 @default.
• W3087932012 hasConceptScore W3087932012C2781308992 @default.
• W3087932012 hasConceptScore W3087932012C55493867 @default.
• W3087932012 hasConceptScore W3087932012C555293320 @default.
• W3087932012 hasConceptScore W3087932012C62478195 @default.
• W3087932012 hasConceptScore W3087932012C71924100 @default.
• W3087932012 hasConceptScore W3087932012C86554907 @default.
• W3087932012 hasConceptScore W3087932012C97029542 @default.
• W3087932012 hasConceptScore W3087932012C98274493 @default.
• W3087932012 hasFunder F4320321001 @default.
• W3087932012 hasFunder F4320321921 @default.
• W3087932012 hasIssue "6" @default.
• W3087932012 hasLocation W30879320121 @default.
• W3087932012 hasOpenAccess W3087932012 @default.
• W3087932012 hasPrimaryLocation W30879320121 @default.

• next